Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy.
DeClue
T J
TJ
Department of Pediatrics, University of South Florida College of Medicine, Tampa 33612-4799.
Malone
J I
JI
Bercu
B B
BB
D001786:Blood Glucose / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006128:Growth / Q000187:drug effects*; D013006:Growth Hormone / Q000493:pharmacokinetics; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D007003:Hypoglycemia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D007223:Infant; D007231:Infant, Newborn; D007328:Insulin / Q000493:pharmacokinetics; D007334:Insulin-Like Growth Factor I / Q000493:pharmacokinetics; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D010180:Pancreatectomy; D010182:Pancreatic Diseases / Q000473:pathology
D001786:Blood Glucose; D007328:Insulin; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D015282:Octreotide